
1.15 Delayed Data As of Aug 12 | ![]() Today’s Change | 0.46 Today|||52-Week Range 3.89 | -49.11% Year-to-Date |
The 5 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 3.50, with a high estimate of 11.00 and a low estimate of 3.00. The median estimate represents a +205.68% increase from the last price of 1.15.
The current consensus among 5 polled investment analysts is to Buy stock in Infinity Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.